Exact Sciences (EXAS) Gains from Investment Securities (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Gains from Investment Securities data on file, last reported at $4.9 million in Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at $4.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $26.8 million (up 1252.49% YoY), and the FY2025 annual result was $26.8 million, up 11813.78% from the prior year.
• Gains from Investment Securities eased to $4.9 million in Q4 2025 per EXAS's latest filing, from $8.7 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $13.3 million in Q3 2021 and troughed at -$26.7 million in Q1 2022.
• A 5-year average of -$2.8 million and a median of $2.0 million in 2023 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities tumbled 1838.62% in 2022, then jumped 178.34% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at -$1.2 million in 2021, then plunged by 1838.62% to -$23.2 million in 2022, then soared by 72.94% to -$6.3 million in 2023, then soared by 184.42% to $5.3 million in 2024, then fell by 7.63% to $4.9 million in 2025.
• Business Quant data shows EXAS's Gains from Investment Securities at $4.9 million in Q4 2025, $8.7 million in Q3 2025, and $4.9 million in Q2 2025.